Abiomed, Inc.ABMDNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-29.4%
5Y CAGR-16.7%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-29.4%/yr
vs -14.8%/yr prior
5Y CAGR
-16.7%/yr
Recent deceleration
Acceleration
-14.6pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202211.98%
202122.84%
202015.38%
201934.08%
201842.87%
201729.84%
201625.29%
201564.73%
201420.83%
201310.45%